Skip to content

Multiple Micronutrient Versus Iron-Folic Acid Supplementation in Pregnant Women in Indonesia

Effect of Multiple Micronutrient Supplementation Versus Iron and Folic Acid Supplementation on Maternal Nutritional Biomarkers and Birth Outcomes Among Pregnant Women in Indonesia

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07725549
Enrollment
66
Registered
2026-07-24
Start date
2025-07-10
Completion date
2026-04-10
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Birth Weight, Maternal Anemia, Maternal Micronutrient Status, Pregnancy

Keywords

Multiple Micronutrient Supplementation, Iron and Folic Acid Supplementation, Maternal Nutrition, Maternal Hemoglobin, Birth Weight, Low Birth Weight

Brief summary

Micronutrient deficiencies during pregnancy may affect the mother's nutritional status and the baby's growth. This study compared two types of daily supplements for pregnant women: a multiple micronutrient supplement and an iron and folic acid supplement. Pregnant women in Indonesia who were at 12 weeks of gestation or earlier were randomly assigned to receive one of the two supplements for eight weeks. The study measured maternal body weight, mid-upper arm circumference, hemoglobin concentration, and serum zinc concentration before and after supplementation. Infant birth weight and the occurrence of low birth weight were assessed after delivery. The purpose of the study was to determine whether multiple micronutrient supplementation produced greater improvements in maternal nutritional indicators and birth outcomes than iron and folic acid supplementation.

Detailed description

This study was designed as a randomized, double-blind, parallel-group trial comparing daily multiple micronutrient supplementation with daily iron and folic acid supplementation among pregnant women in Indonesia. Participants received the assigned supplement for eight weeks. Maternal anthropometric and biochemical indicators were assessed before and after the intervention, and birth outcomes were assessed after delivery. This study was registered retrospectively because prospective registration was inadvertently omitted during study initiation. Information entered in this record was derived from the original study protocol and available study documentation.

Interventions

One tablet was administered orally once daily for eight weeks.

One tablet was administered orally once daily for eight weeks.

Sponsors

Indonesia Timur University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Participants were randomly assigned in a 1:1 ratio to one of two parallel intervention groups: multiple micronutrient supplementation or iron and folic acid supplementation. Each participant received the assigned supplement daily for eight weeks and remained in the same intervention group throughout the study.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

Pregnant women at 12 weeks of gestation or earlier Aged 18 to 40 years No diagnosed chronic disease Willing to complete all study procedures Provided written informed consent

Exclusion criteria

Severe pregnancy complications Known allergy to any supplement ingredient Inability to communicate adequately with the research team Planned relocation from the study area within the following six months

Design outcomes

Primary

MeasureTime frameDescription
Change in Maternal Body WeightBaseline and 8 weeksChange in maternal body weight calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in kilograms.
Change in Maternal Mid-Upper Arm CircumferenceBaseline and 8 weeksChange in maternal mid-upper arm circumference calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in centimeters.
Change in Maternal Hemoglobin ConcentrationBaseline and 8 weeksChange in maternal hemoglobin concentration calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in g/dL. Time Frame:

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026